Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

Celebrate a decade of pharma innovation with The Medicine Maker’s top features, from cancer vaccines to CRISPR breakthroughs.

Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.

As 2024 draws to its conclusion, two experts look at trends in clinical trials and form predictions for 2025.

AI, the Inflation Reduction Act, and a surge in precision medicine; experts look at pharma’s future.

AI solutions can help sift through clinical trial data for effective medical writing, but more people need to use it.

We look back on a decade of breakthroughs in advanced medicine – explore our top articles on cell and gene therapy.

Immunotherapies can accomplish much, but we can only unlock their true power through collaboration.